Latest Shareholder Votes News

Jindalee Lithium has advanced its proposed US Elemental Nasdaq listing and prepared to launch major drilling at McDermitt, but its audited FY26 accounts flag a material uncertainty over ongoing funding. The company ended June with A$13.6 million in cash after raising about A$20.4 million, while reporting a A$7.2 million loss and no operating revenue.

oOh!media’s $1.68-per-share takeover by I Squared Capital has cleared another formal milestone, with the scheme booklet now registered by ASIC. The independent expert considers the offer fair and reasonable, but shareholders must still vote before the proposed 26 November implementation.

Heartland Group Holdings (NZX: HGH, ASX: HGH) more than doubled FY2026 net profit as margins widened, asset quality improved and its proposed TSB merger moved towards a shareholder vote. The bank also reported a 16% fall in restated emissions, though much of its climate-risk work remains incomplete or estimate-driven.

The Supreme Court of New South Wales has approved the shareholder meeting for I Squared Capital’s proposed acquisition of oOh!media at $1.68 per share. An independent expert says the offer falls within its assessed valuation range, but shareholders must still approve the scheme before completion.

The Takeovers Panel has upheld its finding of unacceptable circumstances in Forrestania Resources’ recommended takeover of Zenith Minerals, while requiring both companies to explain what happens if Forrestania falls short of full ownership. The extra disclosure puts listing status, processing access, governance and shareholder voting under sharper scrutiny.

Challenger Gold has locked in US$24 million through five-year unsecured convertible debentures to advance its Hualilán project, with a further US$6.3 million potentially available. The financing carries an 11% coupon and only part of the proceeds is unconditional, leaving shareholder approval and a much larger funding requirement ahead.

Nodestream has deferred four convertible note maturities worth A$8.325 million, including a secured A$4 million note, into October and November 2027. The price of that extra time is a proposed issue of up to 189.2 million options, subject to shareholder approval.

American Tungsten & Antimony has submitted a confidential draft Form F-1 to US regulators, moving its proposed Level III ADR listing on Nasdaq into formal review. The company also extended the Del Sol transaction end date by three weeks, leaving both major initiatives progressing but unfinished.

Carnaby Resources has completed distribution of the scheme booklet for Evolution Mining’s proposed acquisition of its remaining shares. The independent expert supports the deal, but shareholder approval remains the decisive next step.

Ramsay Health Care delivered stronger FY26 earnings, a higher fully franked dividend and improved Funding Group leverage as it prepares to separate Ramsay Santé. The proposed demerger remains conditional, but the company has set a clear timetable for the next phase of its portfolio reshaping.

Titomic has set 30 November 2026 as its current target to complete a proposed move of its parent company from Australia to the United States. The ASX listing would remain, but investors would hold CHESS Depositary Interests in the new US entity if shareholders, the Court and other conditions approve the scheme.

Elixinol Wellness will acquire personalised supplement platform Vitable for headline consideration of A$2.5 million in shares, adding recurring revenue and more than 7,850 active subscribers. The deal could lift combined revenue to A$27 million by 2028, but remains subject to shareholder approval and carries meaningful dilution risk.